Abstract:Global longitudinal strain (GLS) is becoming routinely used to direct the medical management of various cardiac diseases, but its application in pregnancy is unclear. Our objective was to perform a meta-analysis and pool multiple study data to consolidate the evidence base for the role of GLS in the assessment of women with hypertensive disorders of pregnancy (HDP). Electronic database searches were performed in PubMed/Medline and EMBASE for research articles reporting GLS in pregnancies complicated by HDP and… Show more
“…14 In a multicenter observational study of 321 women with preterm preeclampsia, 10% of women had a left ventricle ejection fraction <55% or diastolic dysfunction at 6 months postpartum. 5 Melchiorre et al 15 demonstrated in preeclampsia patients with normal blood pressure (BP) at 1 year after delivery that those with moderate-severe echocardiographic left ventricle anomalies were more likely to develop hypertension at 2 years postpartum (50% risk) in comparison to those with normal or mild left ventricle alterations (3.5% risk). Women with a history of preeclampsia have altered cardiac structure and evidence of diastolic and myocardial dysfunction in the first years after delivery, which may then translate to a trend toward long-term CVD.…”
“…Maternal echocardiography can detect HDP-associated increased left ventricle mass, cardiac remodeling, and diastolic dysfunction. 5‚10–12 Patients with severe or preterm preeclampsia, particularly if they present with dyspnea or signs of volume overload, would probably benefit from an echocardiographic evaluation in the peripartum period to evaluate systodiastolic function. HDP is also the major risk factor for peripartum cardiomyopathy, where women with peripartum cardiomyopathy and preeclampsia exhibit more severe symptoms and signs of heart failure compared to peripartum cardiomyopathy without hypertension.…”
There is widespread acceptance of the increased prevalence of cardiovascular disease occurring within 1 to 2 decades in women following a preeclamptic pregnancy. More recent evidence suggests that the deranged biochemical and echocardiographic findings in women do not resolve in the majority of preeclamptic women following giving birth. Many women continue to be hypertensive in the immediate postnatal period with some exhibiting occult signs of cardiac dysfunction. There is now promising evidence that with close monitoring and effective control of blood pressure control in the immediate postnatal period, women may have persistently lower blood pressures many years after stopping their medication. This review highlights the evidence that delivering effective medical care in the fourth trimester of pregnancy as a means of improving the long-term cardiovascular health of women after a preeclamptic birth.
“…14 In a multicenter observational study of 321 women with preterm preeclampsia, 10% of women had a left ventricle ejection fraction <55% or diastolic dysfunction at 6 months postpartum. 5 Melchiorre et al 15 demonstrated in preeclampsia patients with normal blood pressure (BP) at 1 year after delivery that those with moderate-severe echocardiographic left ventricle anomalies were more likely to develop hypertension at 2 years postpartum (50% risk) in comparison to those with normal or mild left ventricle alterations (3.5% risk). Women with a history of preeclampsia have altered cardiac structure and evidence of diastolic and myocardial dysfunction in the first years after delivery, which may then translate to a trend toward long-term CVD.…”
“…Maternal echocardiography can detect HDP-associated increased left ventricle mass, cardiac remodeling, and diastolic dysfunction. 5‚10–12 Patients with severe or preterm preeclampsia, particularly if they present with dyspnea or signs of volume overload, would probably benefit from an echocardiographic evaluation in the peripartum period to evaluate systodiastolic function. HDP is also the major risk factor for peripartum cardiomyopathy, where women with peripartum cardiomyopathy and preeclampsia exhibit more severe symptoms and signs of heart failure compared to peripartum cardiomyopathy without hypertension.…”
There is widespread acceptance of the increased prevalence of cardiovascular disease occurring within 1 to 2 decades in women following a preeclamptic pregnancy. More recent evidence suggests that the deranged biochemical and echocardiographic findings in women do not resolve in the majority of preeclamptic women following giving birth. Many women continue to be hypertensive in the immediate postnatal period with some exhibiting occult signs of cardiac dysfunction. There is now promising evidence that with close monitoring and effective control of blood pressure control in the immediate postnatal period, women may have persistently lower blood pressures many years after stopping their medication. This review highlights the evidence that delivering effective medical care in the fourth trimester of pregnancy as a means of improving the long-term cardiovascular health of women after a preeclamptic birth.
“…Failure to achieve normal cardiovascular adaptation is associated with development of HDP 12,13 . The maternal hemodynamic alterations associated with HDP are likely to be the consequence of pre‐existing maternal cardiovascular impairment and/or chronic changes in cardiovascular load during pregnancy 14 .…”
Section: Maternal Cardiovascular Function In Pregnancymentioning
confidence: 99%
“…Failure to achieve normal cardiovascular adaptation is associated with development of HDP. 12,13 The maternal hemodynamic alterations associated with HDP are likely to be the consequence of preexisting maternal cardiovascular impairment and/or chronic changes in cardiovascular load during pregnancy. 14 These cardiovascular changes, which correlate with disease severity, [15][16][17][18][19][20] are initiated from the first trimester 21 and can be detected before the condition becomes clinically apparent.…”
Section: Cardiovascular Changes In Women With Hypertensive Disorders ...mentioning
Hypertensive disorders of pregnancy (HDP) are the most common causes of maternal and perinatal morbidity and mortality. They are responsible for 16% of maternal deaths in high‐income countries and approximately 25% in low‐ and middle‐income countries. The impact of HDP can be lifelong as they are a recognized risk factor for future cardiovascular disease. During pregnancy, the cardiovascular system undergoes significant adaptive changes that ensure adequate uteroplacental blood flow and exchange of oxygen and nutrients to nurture and accommodate the developing fetus. Failure to achieve normal cardiovascular adaptation is associated with the development of HDP. Hemodynamic alterations in women with a history of HDP can persist for years and predispose to long‐term cardiovascular morbidity and mortality. Therefore, pregnancy and the postpartum period are an opportunity to identify women with underlying, often unrecognized, cardiovascular risk factors. It is important to develop strategies with lifestyle and therapeutic interventions to reduce the risk of future cardiovascular disease in those who have a history of HDP.
“…If echocardiography is performed, the focus should be on the assessment of concentric hypertrophy, left atrial dilatation [ 47 ] and diastolic dysfunction [ 48 ]. Left ventricular ejection fraction does not appear to be affected by gestational hypertension [ 48 , 49 ], although global longitudinal strain has been shown to be reduced [ 50 ].…”
Section: Echocardiography Of Pregnancy Induced Heart Diseasementioning
Pregnancy is a dynamic process associated with profound hormonally mediated haemodynamic changes which result in structural and functional adaptations in the cardiovascular system. An understanding of the myocardial adaptations is important for echocardiographers and clinicians undertaking or interpreting echocardiograms on pregnant and post-partum women. This guideline, on behalf of the British Society of Echocardiography and United Kingdom Maternal Cardiology Society, reviews the expected echocardiographic findings in normal pregnancy and in different cardiac disease states, as well as echocardiographic signs of decompensation. It aims to lay out a structure for echocardiographic scanning and surveillance during and after pregnancy as well as suggesting practical advice on scanning pregnant women.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.